After finishing at $39.86 in the prior trading day, Cg Oncology Inc. (NASDAQ: CGON) closed at $35.51, down -10.91%. In other words, the price has decreased by -$4.35 from its previous closing price. On the day, 1416690 shares were traded.
Ratios:
Our goal is to gain a better understanding of CGON by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.54 and its Current Ratio is at 9.54. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on February 20, 2024, initiated with a Overweight rating and assigned the stock a target price of $55.
On February 20, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $42.
On February 20, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $75.Cantor Fitzgerald initiated its Overweight rating on February 20, 2024, with a $75 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 ’24 when Decheng Capital Global Life Sc bought 400,000 shares for $19.00 per share. The transaction valued at 7,600,000 led to the insider holds 400,000 shares of the business.
Song Hong Fang bought 263,157 shares of CGON for $4,999,983 on Jan 29 ’24. The Director now owns 613,928 shares after completing the transaction at $19.00 per share. On Jan 29 ’24, another insider, Roche Corleen M., who serves as the CFO & Secretary of the company, bought 2,000 shares for $19.00 each. As a result, the insider paid 38,000 and bolstered with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2.36B and an Enterprise Value of 2.16B. Its current Enterprise Value per Revenue stands at 10.63k whereas that against EBITDA is -46.89.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $28.55. The 50-Day Moving Average of the stock is 41.50, while the 200-Day Moving Average is calculated to be 41.50.
Shares Statistics:
The stock has traded on average 904.56K shares per day over the past 3-months and 515.66k shares per day over the last 10 days, according to various share statistics. A total of 63.48M shares are outstanding, with a floating share count of 27.23M. Insiders hold about 59.04% of the company’s shares, while institutions hold 3.75% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.23 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$0.99 and -$1.36 for the fiscal current year, implying an average EPS of -$1.19. EPS for the following year is -$1.65, with 4 analysts recommending between -$1.12 and -$2.01.
